US Bancorp’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $56.7K | Buy |
2,634
+479
| +22% | +$10.3K | ﹤0.01% | 2716 |
|
2025
Q1 | $49.2K | Buy |
2,155
+1,528
| +244% | +$34.9K | ﹤0.01% | 2751 |
|
2024
Q4 | $16.3K | Buy |
627
+239
| +62% | +$6.21K | ﹤0.01% | 3235 |
|
2024
Q3 | $9.72K | Buy |
388
+89
| +30% | +$2.23K | ﹤0.01% | 3366 |
|
2024
Q2 | $6.41K | Buy |
299
+190
| +174% | +$4.07K | ﹤0.01% | 3428 |
|
2024
Q1 | $2.02K | Sell |
109
-2,411
| -96% | -$44.7K | ﹤0.01% | 3708 |
|
2023
Q4 | $41K | Buy |
2,520
+1,989
| +375% | +$32.3K | ﹤0.01% | 2766 |
|
2023
Q3 | $7.33K | Sell |
531
-102
| -16% | -$1.41K | ﹤0.01% | 3277 |
|
2023
Q2 | $14K | Sell |
633
-4,324
| -87% | -$95.6K | ﹤0.01% | 3107 |
|
2023
Q1 | $108K | Sell |
4,957
-476
| -9% | -$10.4K | ﹤0.01% | 2147 |
|
2022
Q4 | $98.9K | Sell |
5,433
-19,386
| -78% | -$353K | ﹤0.01% | 2196 |
|
2022
Q3 | $564K | Sell |
24,819
-16,842
| -40% | -$383K | ﹤0.01% | 1329 |
|
2022
Q2 | $575K | Sell |
41,661
-3,076
| -7% | -$42.5K | ﹤0.01% | 1363 |
|
2022
Q1 | $1.02M | Sell |
44,737
-600
| -1% | -$13.6K | ﹤0.01% | 1177 |
|
2021
Q4 | $1.69M | Buy |
45,337
+1,095
| +2% | +$40.8K | ﹤0.01% | 973 |
|
2021
Q3 | $1.87M | Buy |
44,242
+40,666
| +1,137% | +$1.72M | ﹤0.01% | 900 |
|
2021
Q2 | $159K | Buy |
3,576
+739
| +26% | +$32.9K | ﹤0.01% | 2064 |
|
2021
Q1 | $102K | Buy |
2,837
+2,792
| +6,204% | +$100K | ﹤0.01% | 2255 |
|
2020
Q4 | $2K | Hold |
45
| – | – | ﹤0.01% | 3522 |
|
2020
Q3 | $1K | Buy |
+45
| New | +$1K | ﹤0.01% | 3492 |
|